STORY FROM: MDL Mass Tort & Class Action Monitor
Farxiga Diabetes Drug Lawsuits Consolidated in New York Federal Court
April 6, 2017
WASHINGTON, D.C. — Users of the type 2 diabetes drug Farxiga who have sued Bristol-Myers Squibb Co. and AstraZeneca in federal court over kidney-related injuries will have their cases initially heard by a single judge in New York, according to an order issued by the U.S. Judicial Panel on Multidistrict Litigation.
The JPML said April 6 that the 18 actions currently pending in six federal district courts share common questions of fact and would benefit from a centralized pre-trial MDL docket.
Plaintiffs allege that ingesting Farxiga, and its “sister drug” Xigduo XR, may result in kidney-related injuries such as diabetic ...